

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.55346482 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.55346482 |
| 3 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.30760781 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.29336242 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 5.29336242 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 5.23580005 |
| 7 | tryptophan catabolic process (GO:0006569) | 4.97500421 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 4.97500421 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 4.97500421 |
| 10 | urea cycle (GO:0000050) | 4.85240068 |
| 11 | urea metabolic process (GO:0019627) | 4.85240068 |
| 12 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.84105894 |
| 13 | alpha-linolenic acid metabolic process (GO:0036109) | 4.83085863 |
| 14 | tryptophan metabolic process (GO:0006568) | 4.77996909 |
| 15 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.77891752 |
| 16 | protein carboxylation (GO:0018214) | 4.77891752 |
| 17 | kynurenine metabolic process (GO:0070189) | 4.73397256 |
| 18 | complement activation, alternative pathway (GO:0006957) | 4.67407268 |
| 19 | bile acid biosynthetic process (GO:0006699) | 4.66744941 |
| 20 | high-density lipoprotein particle remodeling (GO:0034375) | 4.58351378 |
| 21 | mannose metabolic process (GO:0006013) | 4.51610512 |
| 22 | nitrogen cycle metabolic process (GO:0071941) | 4.43137930 |
| 23 | regulation of protein activation cascade (GO:2000257) | 4.40706876 |
| 24 | glyoxylate metabolic process (GO:0046487) | 4.34745558 |
| 25 | phospholipid efflux (GO:0033700) | 4.33572056 |
| 26 | regulation of triglyceride catabolic process (GO:0010896) | 4.29582842 |
| 27 | negative regulation of fibrinolysis (GO:0051918) | 4.27278976 |
| 28 | reverse cholesterol transport (GO:0043691) | 4.20186301 |
| 29 | regulation of complement activation (GO:0030449) | 4.14371499 |
| 30 | sulfur amino acid catabolic process (GO:0000098) | 4.11614139 |
| 31 | regulation of fibrinolysis (GO:0051917) | 4.10087130 |
| 32 | regulation of cholesterol esterification (GO:0010872) | 4.06806273 |
| 33 | phospholipid homeostasis (GO:0055091) | 4.06544091 |
| 34 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.06197820 |
| 35 | protein-lipid complex remodeling (GO:0034368) | 4.04264749 |
| 36 | macromolecular complex remodeling (GO:0034367) | 4.04264749 |
| 37 | plasma lipoprotein particle remodeling (GO:0034369) | 4.04264749 |
| 38 | positive regulation of protein kinase C signaling (GO:0090037) | 4.03081333 |
| 39 | bile acid metabolic process (GO:0008206) | 4.00795795 |
| 40 | cysteine metabolic process (GO:0006534) | 3.98812283 |
| 41 | plasma lipoprotein particle clearance (GO:0034381) | 3.96384541 |
| 42 | plasma lipoprotein particle assembly (GO:0034377) | 3.86156347 |
| 43 | cholesterol efflux (GO:0033344) | 3.83224284 |
| 44 | serine family amino acid catabolic process (GO:0009071) | 3.77955442 |
| 45 | homocysteine metabolic process (GO:0050667) | 3.74573842 |
| 46 | aromatic amino acid family metabolic process (GO:0009072) | 3.73910652 |
| 47 | amino-acid betaine metabolic process (GO:0006577) | 3.73440769 |
| 48 | negative regulation of sterol transport (GO:0032372) | 3.71356289 |
| 49 | negative regulation of cholesterol transport (GO:0032375) | 3.71356289 |
| 50 | low-density lipoprotein particle remodeling (GO:0034374) | 3.61825099 |
| 51 | triglyceride homeostasis (GO:0070328) | 3.59875150 |
| 52 | acylglycerol homeostasis (GO:0055090) | 3.59875150 |
| 53 | tyrosine metabolic process (GO:0006570) | 3.58440506 |
| 54 | endothelial cell chemotaxis (GO:0035767) | 3.57661121 |
| 55 | protein-lipid complex assembly (GO:0065005) | 3.55944020 |
| 56 | amine catabolic process (GO:0009310) | 3.54816511 |
| 57 | cellular biogenic amine catabolic process (GO:0042402) | 3.54816511 |
| 58 | bile acid and bile salt transport (GO:0015721) | 3.52971012 |
| 59 | indolalkylamine metabolic process (GO:0006586) | 3.52902998 |
| 60 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.51644221 |
| 61 | complement activation, classical pathway (GO:0006958) | 3.46092480 |
| 62 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 3.45813813 |
| 63 | plasma lipoprotein particle organization (GO:0071827) | 3.44582753 |
| 64 | imidazole-containing compound metabolic process (GO:0052803) | 3.44253211 |
| 65 | lysine catabolic process (GO:0006554) | 3.43596216 |
| 66 | lysine metabolic process (GO:0006553) | 3.43596216 |
| 67 | alpha-amino acid catabolic process (GO:1901606) | 3.42379328 |
| 68 | regulation of ARF GTPase activity (GO:0032312) | 3.40332199 |
| 69 | complement activation (GO:0006956) | 3.39968798 |
| 70 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.37894302 |
| 71 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.37894302 |
| 72 | protein activation cascade (GO:0072376) | 3.37493987 |
| 73 | positive regulation of lipid catabolic process (GO:0050996) | 3.34237824 |
| 74 | ethanol oxidation (GO:0006069) | 3.32843884 |
| 75 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.30480970 |
| 76 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.30480970 |
| 77 | protein-lipid complex subunit organization (GO:0071825) | 3.29722279 |
| 78 | fibrinolysis (GO:0042730) | 3.29236429 |
| 79 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.27234587 |
| 80 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 3.26937460 |
| 81 | cellular glucuronidation (GO:0052695) | 3.25441653 |
| 82 | acute-phase response (GO:0006953) | 3.24744242 |
| 83 | cholesterol homeostasis (GO:0042632) | 3.18817237 |
| 84 | glycine metabolic process (GO:0006544) | 3.18110456 |
| 85 | blood coagulation, intrinsic pathway (GO:0007597) | 3.17986303 |
| 86 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.16934287 |
| 87 | negative regulation of cell size (GO:0045792) | 3.15677160 |
| 88 | benzene-containing compound metabolic process (GO:0042537) | 3.15653251 |
| 89 | aldehyde catabolic process (GO:0046185) | 3.15251172 |
| 90 | coenzyme catabolic process (GO:0009109) | 3.15133178 |
| 91 | negative regulation of lipase activity (GO:0060192) | 3.13756481 |
| 92 | cellular modified amino acid catabolic process (GO:0042219) | 3.12177682 |
| 93 | sterol homeostasis (GO:0055092) | 3.11950453 |
| 94 | NAD biosynthetic process (GO:0009435) | 3.11504777 |
| 95 | cellular amino acid catabolic process (GO:0009063) | 3.10900800 |
| 96 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.10674420 |
| 97 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.10674420 |
| 98 | modulation by symbiont of host immune response (GO:0052553) | 3.10674420 |
| 99 | positive regulation by symbiont of host defense response (GO:0052509) | 3.10674420 |
| 100 | modulation by symbiont of host defense response (GO:0052031) | 3.10674420 |
| 101 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.10674420 |
| 102 | positive regulation of histone deacetylation (GO:0031065) | 3.10524547 |
| 103 | regulation of ARF protein signal transduction (GO:0032012) | 3.09942935 |
| 104 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.08683145 |
| 105 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.08683145 |
| 106 | cofactor catabolic process (GO:0051187) | 3.06464013 |
| 107 | lipoprotein metabolic process (GO:0042157) | 3.05476978 |
| 108 | semaphorin-plexin signaling pathway (GO:0071526) | 3.05408991 |
| 109 | valine metabolic process (GO:0006573) | 3.00475403 |
| 110 | cytolysis (GO:0019835) | 2.99290636 |
| 111 | positive regulation of Rap GTPase activity (GO:0032854) | 2.98998146 |
| 112 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.95629162 |
| 113 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.95422768 |
| 114 | carnitine shuttle (GO:0006853) | 2.94538528 |
| 115 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.85245870 |
| 116 | cell volume homeostasis (GO:0006884) | 2.77376725 |
| 117 | fatty acid transmembrane transport (GO:1902001) | 2.64467947 |
| 118 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.64273386 |
| 119 | quaternary ammonium group transport (GO:0015697) | 2.59825692 |
| 120 | histone H3-K9 demethylation (GO:0033169) | 2.59797707 |
| 121 | regulation of skeletal muscle contraction (GO:0014819) | 2.57859575 |
| 122 | regulation of gamma-delta T cell activation (GO:0046643) | 2.57143075 |
| 123 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.55934503 |
| 124 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.55414719 |
| 125 | 2-oxoglutarate metabolic process (GO:0006103) | 2.54069124 |
| 126 | creatine metabolic process (GO:0006600) | 2.52630630 |
| 127 | cell-cell junction maintenance (GO:0045217) | 2.51857433 |
| 128 | germinal center formation (GO:0002467) | 2.51812673 |
| 129 | activation of JUN kinase activity (GO:0007257) | 2.50852187 |
| 130 | thymic T cell selection (GO:0045061) | 2.49288316 |
| 131 | phospholipid scrambling (GO:0017121) | 2.47050276 |
| 132 | positive regulation of cholesterol efflux (GO:0010875) | 2.45347761 |
| 133 | histone H3 deacetylation (GO:0070932) | 2.44736885 |
| 134 | regulation of synapse maturation (GO:0090128) | 2.37720683 |
| 135 | negative regulation of granulocyte differentiation (GO:0030853) | 2.37233617 |
| 136 | response to manganese ion (GO:0010042) | 2.37093419 |
| 137 | activation of protein kinase A activity (GO:0034199) | 2.36179711 |
| 138 | regulation of Rap GTPase activity (GO:0032317) | 2.35992829 |
| 139 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.35503851 |
| 140 | positive regulation of protein deacetylation (GO:0090312) | 2.34822079 |
| 141 | positive thymic T cell selection (GO:0045059) | 2.33380684 |
| 142 | histone H4 deacetylation (GO:0070933) | 2.32504197 |
| 143 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.31756971 |
| 144 | carnitine transmembrane transport (GO:1902603) | 2.31336990 |
| 145 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.31031977 |
| 146 | positive regulation of synapse maturation (GO:0090129) | 2.28935853 |
| 147 | cAMP biosynthetic process (GO:0006171) | 2.26213531 |
| 148 | positive regulation of receptor recycling (GO:0001921) | 2.24609561 |
| 149 | regulation of protein kinase C signaling (GO:0090036) | 2.22784432 |
| 150 | adherens junction assembly (GO:0034333) | 2.20893690 |
| 151 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.20168702 |
| 152 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.18855823 |
| 153 | regulation of ruffle assembly (GO:1900027) | 2.18514938 |
| 154 | urinary tract smooth muscle contraction (GO:0014848) | 2.17953971 |
| 155 | amino-acid betaine transport (GO:0015838) | 2.17714981 |
| 156 | carnitine transport (GO:0015879) | 2.17714981 |
| 157 | diacylglycerol metabolic process (GO:0046339) | 2.16708072 |
| 158 | Rap protein signal transduction (GO:0032486) | 2.14789567 |
| 159 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.14018667 |
| 160 | focal adhesion assembly (GO:0048041) | 2.13341389 |
| 161 | cell-substrate adherens junction assembly (GO:0007045) | 2.13341389 |
| 162 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.12482177 |
| 163 | skeletal muscle adaptation (GO:0043501) | 2.12033563 |
| 164 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.11803792 |
| 165 | regulation of fatty acid oxidation (GO:0046320) | 2.10219870 |
| 166 | regulation of p38MAPK cascade (GO:1900744) | 2.09174407 |
| 167 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.07420662 |
| 168 | Rho protein signal transduction (GO:0007266) | 2.07389460 |
| 169 | white fat cell differentiation (GO:0050872) | 2.06602441 |
| 170 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.05090990 |
| 171 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.04681588 |
| 172 | negative regulation of fatty acid transport (GO:2000192) | 2.04239510 |
| 173 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 2.02844495 |
| 174 | macroautophagy (GO:0016236) | 2.02316778 |
| 175 | ovulation (GO:0030728) | 2.01860867 |
| 176 | regulation of histone H3-K27 methylation (GO:0061085) | 2.01366565 |
| 177 | neuronal ion channel clustering (GO:0045161) | 2.00305631 |
| 178 | T cell selection (GO:0045058) | 2.00057030 |
| 179 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 1.99659880 |
| 180 | regulation of fatty acid beta-oxidation (GO:0031998) | 1.99568670 |
| 181 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 1.98307802 |
| 182 | atrioventricular valve morphogenesis (GO:0003181) | 1.98307725 |
| 183 | regulation of apoptotic cell clearance (GO:2000425) | 1.98018474 |
| 184 | chondroitin sulfate catabolic process (GO:0030207) | 1.97325834 |
| 185 | cell junction maintenance (GO:0034331) | 1.95904824 |
| 186 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 1.95099997 |
| 187 | regulation of histone deacetylation (GO:0031063) | 1.94177960 |
| 188 | activation of MAPKKK activity (GO:0000185) | 1.94123846 |
| 189 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 1.93032349 |
| 190 | regulation of cholesterol metabolic process (GO:0090181) | 1.92619619 |
| 191 | positive regulation of cholesterol transport (GO:0032376) | 1.92024819 |
| 192 | positive regulation of sterol transport (GO:0032373) | 1.92024819 |
| 193 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 1.90990466 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.30741985 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.99749312 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.32634562 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.14741170 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.77473266 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.13850716 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.88420494 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.74395254 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.34189792 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.16429067 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.12103069 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.85288235 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.81240930 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.67996255 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.65326334 |
| 16 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.64610929 |
| 17 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.52291254 |
| 18 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.43936447 |
| 19 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.42708139 |
| 20 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.36970518 |
| 21 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 2.35968272 |
| 22 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.35208992 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.33533821 |
| 24 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.25567401 |
| 25 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.21143555 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.21037261 |
| 27 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.19003155 |
| 28 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.14787638 |
| 29 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.08855910 |
| 30 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.08115605 |
| 31 | GATA1_22025678_ChIP-Seq_K562_Human | 2.06506842 |
| 32 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.01423225 |
| 33 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.99928575 |
| 34 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.98116196 |
| 35 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.95661276 |
| 36 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.95348527 |
| 37 | KDM2B_26808549_Chip-Seq_K562_Human | 1.94452437 |
| 38 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.83806336 |
| 39 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.79197905 |
| 40 | P68_20966046_ChIP-Seq_HELA_Human | 1.78234007 |
| 41 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.76566987 |
| 42 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.74464362 |
| 43 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.74059853 |
| 44 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73498699 |
| 45 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.72450369 |
| 46 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.71835676 |
| 47 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.68185716 |
| 48 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.66877112 |
| 49 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.61770260 |
| 50 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.59942249 |
| 51 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.59652593 |
| 52 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.59625298 |
| 53 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.59323198 |
| 54 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.58437888 |
| 55 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.56321243 |
| 56 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.52039135 |
| 57 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.51698428 |
| 58 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.50280738 |
| 59 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.48154491 |
| 60 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.47744860 |
| 61 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.44236699 |
| 62 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.41550740 |
| 63 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.40570495 |
| 64 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.40107884 |
| 65 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.39774619 |
| 66 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.39371173 |
| 67 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.36389153 |
| 68 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.34258798 |
| 69 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.33333589 |
| 70 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.32405012 |
| 71 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.32330647 |
| 72 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.31171708 |
| 73 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.29948114 |
| 74 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.29336961 |
| 75 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.27780365 |
| 76 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.27560038 |
| 77 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.24404608 |
| 78 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23881854 |
| 79 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.23815102 |
| 80 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.23148266 |
| 81 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.23118110 |
| 82 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.23095509 |
| 83 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.22293317 |
| 84 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.21263731 |
| 85 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.21163310 |
| 86 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.21154705 |
| 87 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.20931528 |
| 88 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.20853710 |
| 89 | MAF_26560356_Chip-Seq_TH1_Human | 1.19293207 |
| 90 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.18806195 |
| 91 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.18793024 |
| 92 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.18769929 |
| 93 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.18657458 |
| 94 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.18547978 |
| 95 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.17413761 |
| 96 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16728095 |
| 97 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16377119 |
| 98 | MYB_26560356_Chip-Seq_TH1_Human | 1.16212769 |
| 99 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.15528370 |
| 100 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12420386 |
| 101 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.11043569 |
| 102 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.09916943 |
| 103 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.09708286 |
| 104 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08866559 |
| 105 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.08821832 |
| 106 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.08775342 |
| 107 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.08761158 |
| 108 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.08761158 |
| 109 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.08701865 |
| 110 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07556355 |
| 111 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.07279283 |
| 112 | MYB_26560356_Chip-Seq_TH2_Human | 1.06985644 |
| 113 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.06795678 |
| 114 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05040299 |
| 115 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.04818290 |
| 116 | SA1_27219007_Chip-Seq_Bcells_Human | 1.03281978 |
| 117 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.02862606 |
| 118 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02812272 |
| 119 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.02628747 |
| 120 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.02298687 |
| 121 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.01833178 |
| 122 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.01114750 |
| 123 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.01101499 |
| 124 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.00341061 |
| 125 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.99922400 |
| 126 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.99761819 |
| 127 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.99534837 |
| 128 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.98224219 |
| 129 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.98190744 |
| 130 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.97828412 |
| 131 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.95150434 |
| 132 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.95038678 |
| 133 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94689425 |
| 134 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.94330766 |
| 135 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.94221280 |
| 136 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93884020 |
| 137 | GATA2_19941826_ChIP-Seq_K562_Human | 0.93847092 |
| 138 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93406026 |
| 139 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91985710 |
| 140 | GATA1_19941826_ChIP-Seq_K562_Human | 0.91698709 |
| 141 | UTX_26944678_Chip-Seq_JUKART_Human | 0.91032895 |
| 142 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.90484322 |
| 143 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.89968327 |
| 144 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.89911296 |
| 145 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86417841 |
| 146 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.85949776 |
| 147 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83515856 |
| 148 | GATA3_26560356_Chip-Seq_TH2_Human | 0.83255463 |
| 149 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.82719036 |
| 150 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.81304831 |
| 151 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.75682201 |
| 152 | MYC_22102868_ChIP-Seq_BL_Human | 0.75041147 |
| 153 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.73967452 |
| 154 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.72300028 |
| 155 | MAF_26560356_Chip-Seq_TH2_Human | 0.71438747 |
| 156 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71246872 |
| 157 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.70812888 |
| 158 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.68962731 |
| 159 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.68257799 |
| 160 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.67613068 |
| 161 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.65561558 |
| 162 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.64936360 |
| 163 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.63567321 |
| 164 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.62964841 |
| 165 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.61406645 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.01557084 |
| 2 | MP0005360_urolithiasis | 5.30623122 |
| 3 | MP0005365_abnormal_bile_salt | 4.62809456 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.52129951 |
| 5 | MP0009840_abnormal_foam_cell | 3.62507301 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.49524848 |
| 7 | MP0003191_abnormal_cellular_cholesterol | 3.07964516 |
| 8 | MP0003252_abnormal_bile_duct | 3.03550952 |
| 9 | MP0000751_myopathy | 2.96344729 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.88607924 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.87243703 |
| 12 | MP0000013_abnormal_adipose_tissue | 2.54589960 |
| 13 | MP0005409_darkened_coat_color | 2.38261927 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.35299133 |
| 15 | MP0005666_abnormal_adipose_tissue | 2.29940213 |
| 16 | MP0005058_abnormal_lysosome_morphology | 2.28033624 |
| 17 | MP0005083_abnormal_biliary_tract | 2.27586002 |
| 18 | MP0005375_adipose_tissue_phenotype | 2.14494627 |
| 19 | MP0003436_decreased_susceptibility_to | 2.14410507 |
| 20 | MP0000609_abnormal_liver_physiology | 2.06295469 |
| 21 | MP0004036_abnormal_muscle_relaxation | 2.06007555 |
| 22 | MP0003879_abnormal_hair_cell | 2.00630951 |
| 23 | MP0002933_joint_inflammation | 1.98572928 |
| 24 | MP0005464_abnormal_platelet_physiology | 1.97664617 |
| 25 | MP0005332_abnormal_amino_acid | 1.88667006 |
| 26 | MP0000003_abnormal_adipose_tissue | 1.86356122 |
| 27 | MP0001666_abnormal_nutrient_absorption | 1.85237644 |
| 28 | MP0002419_abnormal_innate_immunity | 1.82352365 |
| 29 | MP0006082_CNS_inflammation | 1.80279496 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 1.79884946 |
| 31 | MP0003279_aneurysm | 1.77614555 |
| 32 | MP0003195_calcinosis | 1.74074377 |
| 33 | MP0002118_abnormal_lipid_homeostasis | 1.73181190 |
| 34 | MP0008260_abnormal_autophagy | 1.72671426 |
| 35 | MP0006138_congestive_heart_failure | 1.70337099 |
| 36 | MP0002249_abnormal_larynx_morphology | 1.67548425 |
| 37 | MP0005167_abnormal_blood-brain_barrier | 1.64470352 |
| 38 | MP0003172_abnormal_lysosome_physiology | 1.62454778 |
| 39 | MP0002822_catalepsy | 1.60722158 |
| 40 | MP0004084_abnormal_cardiac_muscle | 1.60284731 |
| 41 | MP0005319_abnormal_enzyme/_coenzyme | 1.58092589 |
| 42 | MP0001849_ear_inflammation | 1.57401875 |
| 43 | MP0003656_abnormal_erythrocyte_physiolo | 1.57314417 |
| 44 | MP0001958_emphysema | 1.57261524 |
| 45 | MP0008469_abnormal_protein_level | 1.54902337 |
| 46 | MP0005025_abnormal_response_to | 1.53924379 |
| 47 | MP0009785_altered_susceptibility_to | 1.53261039 |
| 48 | MP0003724_increased_susceptibility_to | 1.52557360 |
| 49 | MP0004019_abnormal_vitamin_homeostasis | 1.49894426 |
| 50 | MP0009764_decreased_sensitivity_to | 1.48520816 |
| 51 | MP0009384_cardiac_valve_regurgitation | 1.48426074 |
| 52 | MP0001800_abnormal_humoral_immune | 1.48375432 |
| 53 | MP0000685_abnormal_immune_system | 1.48239707 |
| 54 | MP0005535_abnormal_body_temperature | 1.43750236 |
| 55 | MP0005670_abnormal_white_adipose | 1.41431016 |
| 56 | MP0001853_heart_inflammation | 1.41194540 |
| 57 | MP0003045_fibrosis | 1.40553855 |
| 58 | MP0003868_abnormal_feces_composition | 1.40041809 |
| 59 | MP0005387_immune_system_phenotype | 1.39086592 |
| 60 | MP0001790_abnormal_immune_system | 1.39086592 |
| 61 | MP0001764_abnormal_homeostasis | 1.38616860 |
| 62 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.36067882 |
| 63 | MP0004145_abnormal_muscle_electrophysio | 1.35848998 |
| 64 | MP0002452_abnormal_antigen_presenting | 1.32942438 |
| 65 | MP0005000_abnormal_immune_tolerance | 1.32901170 |
| 66 | MP0004858_abnormal_nervous_system | 1.31236159 |
| 67 | MP0002723_abnormal_immune_serum | 1.31148110 |
| 68 | MP0009763_increased_sensitivity_to | 1.31031479 |
| 69 | MP0001348_abnormal_lacrimal_gland | 1.26522293 |
| 70 | MP0000678_abnormal_parathyroid_gland | 1.26191740 |
| 71 | MP0005671_abnormal_response_to | 1.25605861 |
| 72 | MP0000569_abnormal_digit_pigmentation | 1.25478777 |
| 73 | MP0003303_peritoneal_inflammation | 1.22713283 |
| 74 | MP0000604_amyloidosis | 1.21904351 |
| 75 | MP0003690_abnormal_glial_cell | 1.20918014 |
| 76 | MP0000598_abnormal_liver_morphology | 1.20427144 |
| 77 | MP0000747_muscle_weakness | 1.19784418 |
| 78 | MP0004185_abnormal_adipocyte_glucose | 1.18595835 |
| 79 | MP0005503_abnormal_tendon_morphology | 1.18571453 |
| 80 | MP0001845_abnormal_inflammatory_respons | 1.18470653 |
| 81 | MP0005330_cardiomyopathy | 1.17745522 |
| 82 | MP0005451_abnormal_body_composition | 1.17557180 |
| 83 | MP0003183_abnormal_peptide_metabolism | 1.15435748 |
| 84 | MP0004087_abnormal_muscle_fiber | 1.14891223 |
| 85 | MP0002148_abnormal_hypersensitivity_rea | 1.13098900 |
| 86 | MP0003646_muscle_fatigue | 1.12311021 |
| 87 | MP0000767_abnormal_smooth_muscle | 1.12111531 |
| 88 | MP0003300_gastrointestinal_ulcer | 1.11540494 |
| 89 | MP0004859_abnormal_synaptic_plasticity | 1.10806074 |
| 90 | MP0003186_abnormal_redox_activity | 1.09385394 |
| 91 | MP0005076_abnormal_cell_differentiation | 1.09287212 |
| 92 | MP0001819_abnormal_immune_cell | 1.08799290 |
| 93 | MP0002420_abnormal_adaptive_immunity | 1.08529525 |
| 94 | MP0002254_reproductive_system_inflammat | 1.07930571 |
| 95 | MP0002998_abnormal_bone_remodeling | 1.06264896 |
| 96 | MP0002108_abnormal_muscle_morphology | 1.06113021 |
| 97 | MP0000749_muscle_degeneration | 1.05926737 |
| 98 | MP0003453_abnormal_keratinocyte_physiol | 1.05003258 |
| 99 | MP0009643_abnormal_urine_homeostasis | 1.04931673 |
| 100 | MP0004947_skin_inflammation | 1.04927244 |
| 101 | MP0005647_abnormal_sex_gland | 1.04741150 |
| 102 | MP0003011_delayed_dark_adaptation | 1.04515882 |
| 103 | MP0004130_abnormal_muscle_cell | 1.03692252 |
| 104 | MP0001502_abnormal_circadian_rhythm | 1.03177586 |
| 105 | MP0000759_abnormal_skeletal_muscle | 0.98518696 |
| 106 | MP0005595_abnormal_vascular_smooth | 0.98167126 |
| 107 | MP0009697_abnormal_copulation | 0.96807689 |
| 108 | MP0003075_altered_response_to | 0.95524059 |
| 109 | MP0000689_abnormal_spleen_morphology | 0.95112596 |
| 110 | MP0004510_myositis | 0.94304231 |
| 111 | MP0001533_abnormal_skeleton_physiology | 0.93790296 |
| 112 | MP0003091_abnormal_cell_migration | 0.92556793 |
| 113 | MP0009780_abnormal_chondrocyte_physiolo | 0.92512759 |
| 114 | MP0002405_respiratory_system_inflammati | 0.92160837 |
| 115 | MP0008961_abnormal_basal_metabolism | 0.91762985 |
| 116 | MP0005620_abnormal_muscle_contractility | 0.91335194 |
| 117 | MP0001501_abnormal_sleep_pattern | 0.89591102 |
| 118 | MP0005075_abnormal_melanosome_morpholog | 0.88558810 |
| 119 | MP0009765_abnormal_xenobiotic_induced | 0.87819980 |
| 120 | MP0010368_abnormal_lymphatic_system | 0.87486976 |
| 121 | MP0000716_abnormal_immune_system | 0.87410197 |
| 122 | MP0004043_abnormal_pH_regulation | 0.86716289 |
| 123 | MP0009642_abnormal_blood_homeostasis | 0.86704672 |
| 124 | MP0005448_abnormal_energy_balance | 0.85819996 |
| 125 | MP0001765_abnormal_ion_homeostasis | 0.85209325 |
| 126 | MP0002971_abnormal_brown_adipose | 0.84768823 |
| 127 | MP0009278_abnormal_bone_marrow | 0.84306764 |
| 128 | MP0002166_altered_tumor_susceptibility | 0.83530173 |
| 129 | MP0001873_stomach_inflammation | 0.83285325 |
| 130 | MP0008874_decreased_physiological_sensi | 0.82848062 |
| 131 | MP0005397_hematopoietic_system_phenotyp | 0.82596267 |
| 132 | MP0001545_abnormal_hematopoietic_system | 0.82596267 |
| 133 | MP0000465_gastrointestinal_hemorrhage | 0.80974860 |
| 134 | MP0005334_abnormal_fat_pad | 0.80481575 |
| 135 | MP0010155_abnormal_intestine_physiology | 0.80423347 |
| 136 | MP0002970_abnormal_white_adipose | 0.80364237 |
| 137 | MP0000733_abnormal_muscle_development | 0.80184713 |
| 138 | MP0005166_decreased_susceptibility_to | 0.80078338 |
| 139 | MP0002106_abnormal_muscle_physiology | 0.79442769 |
| 140 | MP0002398_abnormal_bone_marrow | 0.78973915 |
| 141 | MP0002332_abnormal_exercise_endurance | 0.78735404 |
| 142 | MP0005369_muscle_phenotype | 0.78554578 |
| 143 | MP0002396_abnormal_hematopoietic_system | 0.76218238 |
| 144 | MP0010630_abnormal_cardiac_muscle | 0.75152136 |
| 145 | MP0003763_abnormal_thymus_physiology | 0.75031116 |
| 146 | MP0002722_abnormal_immune_system | 0.74963444 |
| 147 | MP0002928_abnormal_bile_duct | 0.74547855 |
| 148 | MP0005174_abnormal_tail_pigmentation | 0.74290902 |
| 149 | MP0002429_abnormal_blood_cell | 0.74021155 |
| 150 | MP0000343_altered_response_to | 0.73422366 |
| 151 | MP0002269_muscular_atrophy | 0.73312225 |
| 152 | MP0002796_impaired_skin_barrier | 0.71357697 |
| 153 | MP0003705_abnormal_hypodermis_morpholog | 0.69022237 |
| 154 | MP0003329_amyloid_beta_deposits | 0.66856137 |
| 155 | MP0004381_abnormal_hair_follicle | 0.66116224 |
| 156 | MP0000249_abnormal_blood_vessel | 0.65447496 |
| 157 | MP0002136_abnormal_kidney_physiology | 0.65248410 |
| 158 | MP0009115_abnormal_fat_cell | 0.65199254 |
| 159 | MP0000371_diluted_coat_color | 0.64954167 |
| 160 | MP0008873_increased_physiological_sensi | 0.61266590 |
| 161 | MP0005376_homeostasis/metabolism_phenot | 0.61075639 |
| 162 | MP0005636_abnormal_mineral_homeostasis | 0.60778302 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Obstructive sleep apnea (HP:0002870) | 5.94008249 |
| 2 | Deep venous thrombosis (HP:0002625) | 5.47128980 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 5.41383844 |
| 4 | Complement deficiency (HP:0004431) | 5.28973501 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.19412936 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.15903330 |
| 7 | Xanthomatosis (HP:0000991) | 4.98496768 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.94499527 |
| 9 | Joint hemorrhage (HP:0005261) | 4.90858651 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.67679382 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 4.45997255 |
| 12 | Hypobetalipoproteinemia (HP:0003563) | 4.42828804 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 4.34660109 |
| 14 | Abnormality of complement system (HP:0005339) | 4.02772825 |
| 15 | J-shaped sella turcica (HP:0002680) | 3.90744292 |
| 16 | Broad face (HP:0000283) | 3.81296745 |
| 17 | Hypolipoproteinemia (HP:0010981) | 3.64910656 |
| 18 | Abnormality of the common coagulation pathway (HP:0010990) | 3.59727719 |
| 19 | Nuclear cataract (HP:0100018) | 3.55499905 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 3.53542606 |
| 21 | Myocardial infarction (HP:0001658) | 3.50412398 |
| 22 | Epidermoid cyst (HP:0200040) | 3.49097277 |
| 23 | Recurrent bacterial skin infections (HP:0005406) | 3.47786418 |
| 24 | Cervical subluxation (HP:0003308) | 3.47252169 |
| 25 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.46872118 |
| 26 | Hypercholesterolemia (HP:0003124) | 3.45890839 |
| 27 | Hyperammonemia (HP:0001987) | 3.43808572 |
| 28 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.42760899 |
| 29 | Cerebral aneurysm (HP:0004944) | 3.42710333 |
| 30 | Abnormality of methionine metabolism (HP:0010901) | 3.36031129 |
| 31 | Stridor (HP:0010307) | 3.35564168 |
| 32 | Glomerulonephritis (HP:0000099) | 3.35261382 |
| 33 | Increased connective tissue (HP:0009025) | 3.34894054 |
| 34 | Lymphangioma (HP:0100764) | 3.32502645 |
| 35 | Exercise-induced myalgia (HP:0003738) | 3.29911256 |
| 36 | Recurrent abscess formation (HP:0002722) | 3.27936355 |
| 37 | Gingival bleeding (HP:0000225) | 3.27559468 |
| 38 | Eczematoid dermatitis (HP:0000976) | 3.23038322 |
| 39 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.18179856 |
| 40 | Ketosis (HP:0001946) | 3.16556115 |
| 41 | Fat malabsorption (HP:0002630) | 3.14033486 |
| 42 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.13847326 |
| 43 | Asymmetric septal hypertrophy (HP:0001670) | 3.08616322 |
| 44 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.07728263 |
| 45 | Thin bony cortex (HP:0002753) | 3.05268366 |
| 46 | Abnormality of the intrinsic pathway (HP:0010989) | 3.01565876 |
| 47 | Aortic regurgitation (HP:0001659) | 3.00769391 |
| 48 | Neoplasm of the heart (HP:0100544) | 2.89290441 |
| 49 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.88849879 |
| 50 | Muscle fiber splitting (HP:0003555) | 2.86514757 |
| 51 | Vacuolated lymphocytes (HP:0001922) | 2.86156740 |
| 52 | Conjugated hyperbilirubinemia (HP:0002908) | 2.80868022 |
| 53 | Amyloidosis (HP:0011034) | 2.80534249 |
| 54 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.80331773 |
| 55 | Hyperglycinemia (HP:0002154) | 2.79140150 |
| 56 | Type 1 muscle fiber predominance (HP:0003803) | 2.78209374 |
| 57 | Bundle branch block (HP:0011710) | 2.70452030 |
| 58 | Menorrhagia (HP:0000132) | 2.68899335 |
| 59 | Hyperglycinuria (HP:0003108) | 2.65607806 |
| 60 | Recurrent skin infections (HP:0001581) | 2.64019754 |
| 61 | Joint stiffness (HP:0001387) | 2.60393513 |
| 62 | Epistaxis (HP:0000421) | 2.58559872 |
| 63 | Hypoglycemic coma (HP:0001325) | 2.56684754 |
| 64 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.55156729 |
| 65 | Abnormality of glycine metabolism (HP:0010895) | 2.55156729 |
| 66 | Axonal loss (HP:0003447) | 2.54371485 |
| 67 | Hyperbilirubinemia (HP:0002904) | 2.53915290 |
| 68 | Increased variability in muscle fiber diameter (HP:0003557) | 2.53225252 |
| 69 | Upper motor neuron abnormality (HP:0002127) | 2.52927615 |
| 70 | Steatorrhea (HP:0002570) | 2.52462416 |
| 71 | Autoimmune thrombocytopenia (HP:0001973) | 2.51430667 |
| 72 | Abnormality of nucleobase metabolism (HP:0010932) | 2.51023089 |
| 73 | Myopathic facies (HP:0002058) | 2.48134795 |
| 74 | Deformed sella turcica (HP:0002681) | 2.45427924 |
| 75 | Distal lower limb muscle weakness (HP:0009053) | 2.42752183 |
| 76 | Abnormality of the fingertips (HP:0001211) | 2.41702650 |
| 77 | Aortic aneurysm (HP:0004942) | 2.41433722 |
| 78 | Malnutrition (HP:0004395) | 2.40831364 |
| 79 | Increased cerebral lipofuscin (HP:0011813) | 2.39507823 |
| 80 | Distal lower limb amyotrophy (HP:0008944) | 2.38708783 |
| 81 | Nephritis (HP:0000123) | 2.35237045 |
| 82 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.33459874 |
| 83 | Bulbar palsy (HP:0001283) | 2.33444701 |
| 84 | Aneurysm (HP:0002617) | 2.33339776 |
| 85 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.32210300 |
| 86 | Sleep apnea (HP:0010535) | 2.28817160 |
| 87 | Mitral stenosis (HP:0001718) | 2.27891115 |
| 88 | Broad metatarsal (HP:0001783) | 2.26951224 |
| 89 | Bronchomalacia (HP:0002780) | 2.26928042 |
| 90 | Emphysema (HP:0002097) | 2.25705026 |
| 91 | Abnormal atrioventricular conduction (HP:0005150) | 2.25423872 |
| 92 | Spinal canal stenosis (HP:0003416) | 2.25086433 |
| 93 | Difficulty running (HP:0009046) | 2.24667896 |
| 94 | Thrombophlebitis (HP:0004418) | 2.24437824 |
| 95 | Impaired platelet aggregation (HP:0003540) | 2.23576682 |
| 96 | Abnormal platelet function (HP:0011869) | 2.23576682 |
| 97 | Visceral angiomatosis (HP:0100761) | 2.23074593 |
| 98 | Hepatocellular carcinoma (HP:0001402) | 2.22119581 |
| 99 | Hypochromic microcytic anemia (HP:0004840) | 2.22075301 |
| 100 | Easy fatigability (HP:0003388) | 2.21901929 |
| 101 | Hyporeflexia of lower limbs (HP:0002600) | 2.19022987 |
| 102 | Round ear (HP:0100830) | 2.19013033 |
| 103 | Heart block (HP:0012722) | 2.18244096 |
| 104 | Abnormality of iron homeostasis (HP:0011031) | 2.18124345 |
| 105 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.17966798 |
| 106 | Abnormality of purine metabolism (HP:0004352) | 2.17444706 |
| 107 | EMG: neuropathic changes (HP:0003445) | 2.16404794 |
| 108 | Spontaneous abortion (HP:0005268) | 2.14640728 |
| 109 | Periodontitis (HP:0000704) | 2.14388986 |
| 110 | Neurofibrillary tangles (HP:0002185) | 2.13446181 |
| 111 | Gingivitis (HP:0000230) | 2.12656479 |
| 112 | Abnormality of macrophages (HP:0004311) | 2.12433838 |
| 113 | Esophageal varix (HP:0002040) | 2.12321784 |
| 114 | Hemorrhage of the eye (HP:0011885) | 2.11733401 |
| 115 | Skin nodule (HP:0200036) | 2.11688965 |
| 116 | Abnormality of serum amino acid levels (HP:0003112) | 2.10631124 |
| 117 | Recurrent fungal infections (HP:0002841) | 2.09466137 |
| 118 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.09219714 |
| 119 | Sensorimotor neuropathy (HP:0007141) | 2.09035478 |
| 120 | Vascular calcification (HP:0004934) | 2.08541638 |
| 121 | Pulmonary embolism (HP:0002204) | 2.07326143 |
| 122 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.06731239 |
| 123 | Cerebral palsy (HP:0100021) | 2.05507440 |
| 124 | Shallow orbits (HP:0000586) | 2.05431401 |
| 125 | Prolonged bleeding time (HP:0003010) | 2.04046812 |
| 126 | Papilledema (HP:0001085) | 2.02684389 |
| 127 | Supranuclear gaze palsy (HP:0000605) | 2.02502009 |
| 128 | Gastrointestinal inflammation (HP:0004386) | 2.02206026 |
| 129 | Prolonged QT interval (HP:0001657) | 2.02147431 |
| 130 | Acanthocytosis (HP:0001927) | 2.01572841 |
| 131 | Hemangiomatosis (HP:0007461) | 1.99934727 |
| 132 | Dysostosis multiplex (HP:0000943) | 1.99371119 |
| 133 | Colitis (HP:0002583) | 1.98576964 |
| 134 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.97109497 |
| 135 | Dicarboxylic aciduria (HP:0003215) | 1.97109497 |
| 136 | Metabolic acidosis (HP:0001942) | 1.96449390 |
| 137 | Ulnar deviation of the wrist (HP:0003049) | 1.96312262 |
| 138 | Delayed CNS myelination (HP:0002188) | 1.96183099 |
| 139 | Pancreatitis (HP:0001733) | 1.95709242 |
| 140 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.95699922 |
| 141 | Biconcave vertebral bodies (HP:0004586) | 1.95681301 |
| 142 | Hypertriglyceridemia (HP:0002155) | 1.95201161 |
| 143 | Inflammation of the large intestine (HP:0002037) | 1.92906808 |
| 144 | Spastic diplegia (HP:0001264) | 1.92807957 |
| 145 | Urticaria (HP:0001025) | 1.92569634 |
| 146 | Abnormality of lateral ventricle (HP:0030047) | 1.91834565 |
| 147 | Spontaneous hematomas (HP:0007420) | 1.90629971 |
| 148 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.90487109 |
| 149 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.90487109 |
| 150 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.90487109 |
| 151 | Muscle fiber inclusion bodies (HP:0100299) | 1.90082149 |
| 152 | Ketoacidosis (HP:0001993) | 1.89734533 |
| 153 | Cholelithiasis (HP:0001081) | 1.89515000 |
| 154 | Increased serum ferritin (HP:0003281) | 1.89474385 |
| 155 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.88447125 |
| 156 | Mucopolysacchariduria (HP:0008155) | 1.88447125 |
| 157 | Poikilocytosis (HP:0004447) | 1.88436458 |
| 158 | Purpura (HP:0000979) | 1.88258668 |
| 159 | Mitral regurgitation (HP:0001653) | 1.87616396 |
| 160 | Flat acetabular roof (HP:0003180) | 1.85213357 |
| 161 | Difficulty climbing stairs (HP:0003551) | 1.81718522 |
| 162 | Increased IgE level (HP:0003212) | 1.80508050 |
| 163 | Atelectasis (HP:0100750) | 1.80024597 |
| 164 | Distal upper limb amyotrophy (HP:0007149) | 1.77900784 |
| 165 | Upper limb amyotrophy (HP:0009129) | 1.77900784 |
| 166 | Flared iliac wings (HP:0002869) | 1.77776355 |
| 167 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.77231643 |
| 168 | Stroke (HP:0001297) | 1.77069484 |
| 169 | Sudden death (HP:0001699) | 1.75380264 |
| 170 | Ankle clonus (HP:0011448) | 1.75007552 |
| 171 | Nemaline bodies (HP:0003798) | 1.74855933 |
| 172 | Onion bulb formation (HP:0003383) | 1.73717918 |
| 173 | Metaphyseal cupping (HP:0003021) | 1.71657956 |
| 174 | Oligomenorrhea (HP:0000876) | 1.71058787 |
| 175 | Ventricular arrhythmia (HP:0004308) | 1.69765809 |
| 176 | Thoracic kyphosis (HP:0002942) | 1.69071495 |
| 177 | Hypoplasia of the odontoid process (HP:0003311) | 1.67853565 |
| 178 | Hyperacusis (HP:0010780) | 1.67338373 |
| 179 | Cerebral inclusion bodies (HP:0100314) | 1.66471924 |
| 180 | Syncope (HP:0001279) | 1.66261406 |
| 181 | Spinal rigidity (HP:0003306) | 1.65220443 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.30125160 |
| 2 | ERN1 | 3.21805244 |
| 3 | BCKDK | 3.15979590 |
| 4 | TNK2 | 3.05551597 |
| 5 | TAOK3 | 3.03831326 |
| 6 | TYK2 | 2.95260877 |
| 7 | TGFBR2 | 2.74604536 |
| 8 | MAP3K14 | 2.67468217 |
| 9 | FGFR4 | 2.58035745 |
| 10 | IRAK3 | 2.43035512 |
| 11 | KIT | 2.41714486 |
| 12 | TBK1 | 2.34565848 |
| 13 | SIK1 | 2.26737133 |
| 14 | MARK2 | 2.16164594 |
| 15 | MAP3K6 | 2.08439372 |
| 16 | CSF1R | 2.03898558 |
| 17 | BLK | 1.94933733 |
| 18 | IRAK4 | 1.89870923 |
| 19 | TXK | 1.87383397 |
| 20 | IKBKE | 1.82810612 |
| 21 | CDC42BPA | 1.82174646 |
| 22 | MAP2K6 | 1.80244309 |
| 23 | JAK1 | 1.79232641 |
| 24 | FLT3 | 1.72869765 |
| 25 | MAP2K3 | 1.72181122 |
| 26 | PKN2 | 1.70539777 |
| 27 | CAMK1D | 1.63531992 |
| 28 | PRPF4B | 1.62938348 |
| 29 | ZAP70 | 1.61621400 |
| 30 | PRKD2 | 1.54774693 |
| 31 | RIPK4 | 1.54553684 |
| 32 | JAK3 | 1.51884892 |
| 33 | NEK9 | 1.48359195 |
| 34 | TRIB3 | 1.46807053 |
| 35 | IKBKB | 1.44950737 |
| 36 | BTK | 1.43523049 |
| 37 | MAP3K13 | 1.42408385 |
| 38 | CSK | 1.40739790 |
| 39 | NTRK3 | 1.40369842 |
| 40 | JAK2 | 1.35976069 |
| 41 | EPHB1 | 1.33028341 |
| 42 | PRKD3 | 1.32199073 |
| 43 | MAPK11 | 1.30555174 |
| 44 | PIK3CG | 1.30025449 |
| 45 | HCK | 1.26243494 |
| 46 | GRK6 | 1.21622796 |
| 47 | SYK | 1.21389535 |
| 48 | TEC | 1.21234001 |
| 49 | PTK6 | 1.17774415 |
| 50 | RPS6KA2 | 1.16068735 |
| 51 | TAOK1 | 1.15413687 |
| 52 | ITK | 1.14411266 |
| 53 | INSRR | 1.13653565 |
| 54 | CAMK1G | 1.07913906 |
| 55 | STK10 | 1.07498048 |
| 56 | TESK1 | 1.06578988 |
| 57 | HIPK2 | 1.03883547 |
| 58 | MAP3K10 | 1.03331628 |
| 59 | CAMKK1 | 1.03129090 |
| 60 | OBSCN | 1.00734924 |
| 61 | MUSK | 1.00037153 |
| 62 | BMX | 0.99782940 |
| 63 | LYN | 0.98234879 |
| 64 | LCK | 0.95308814 |
| 65 | MAPKAPK3 | 0.94068171 |
| 66 | TTN | 0.92492564 |
| 67 | MAPK15 | 0.91973430 |
| 68 | CDK6 | 0.91936353 |
| 69 | MAPK12 | 0.91472428 |
| 70 | PRKAA2 | 0.91390256 |
| 71 | FGFR3 | 0.89703881 |
| 72 | AKT3 | 0.89702115 |
| 73 | MAP3K1 | 0.86358039 |
| 74 | CHUK | 0.86100514 |
| 75 | MAP3K7 | 0.85676551 |
| 76 | RPS6KC1 | 0.84848176 |
| 77 | RPS6KL1 | 0.84848176 |
| 78 | CAMK1 | 0.84026185 |
| 79 | FES | 0.82267261 |
| 80 | PHKG2 | 0.79586913 |
| 81 | PHKG1 | 0.79586913 |
| 82 | PIM1 | 0.77546544 |
| 83 | NME1 | 0.77362908 |
| 84 | MAPK7 | 0.76168694 |
| 85 | MAPK4 | 0.73951386 |
| 86 | DMPK | 0.73423781 |
| 87 | ERBB4 | 0.73251329 |
| 88 | MYLK | 0.72496738 |
| 89 | EEF2K | 0.72356132 |
| 90 | MAP3K3 | 0.72237417 |
| 91 | STK38 | 0.71425826 |
| 92 | TRPM7 | 0.69529803 |
| 93 | PRKAA1 | 0.68685426 |
| 94 | KDR | 0.68324214 |
| 95 | PDGFRA | 0.68154783 |
| 96 | DDR2 | 0.66465981 |
| 97 | SMG1 | 0.66067470 |
| 98 | SIK2 | 0.64868381 |
| 99 | PRKD1 | 0.64218767 |
| 100 | MST1R | 0.63338562 |
| 101 | PTK2B | 0.61930275 |
| 102 | ABL2 | 0.60821126 |
| 103 | CDK12 | 0.60197595 |
| 104 | PDK1 | 0.59087133 |
| 105 | RIPK1 | 0.58829277 |
| 106 | PRKCH | 0.58130210 |
| 107 | PDGFRB | 0.56315331 |
| 108 | EGFR | 0.55831154 |
| 109 | CDK4 | 0.55711933 |
| 110 | SGK223 | 0.55414554 |
| 111 | SGK494 | 0.55414554 |
| 112 | GRK7 | 0.53694412 |
| 113 | SGK3 | 0.52822440 |
| 114 | EPHA2 | 0.52735796 |
| 115 | PRKCQ | 0.51505756 |
| 116 | SGK2 | 0.51395830 |
| 117 | RET | 0.50871612 |
| 118 | ABL1 | 0.49912585 |
| 119 | GRK1 | 0.49845464 |
| 120 | MAPK8 | 0.47580165 |
| 121 | SIK3 | 0.47471355 |
| 122 | ROCK1 | 0.47363285 |
| 123 | STK4 | 0.47353572 |
| 124 | MATK | 0.47164543 |
| 125 | PDPK1 | 0.45932763 |
| 126 | CLK1 | 0.45551695 |
| 127 | MARK3 | 0.43764935 |
| 128 | MAPK10 | 0.43129980 |
| 129 | TIE1 | 0.41134292 |
| 130 | IGF1R | 0.40997089 |
| 131 | RPS6KA6 | 0.40896050 |
| 132 | IRAK1 | 0.40802348 |
| 133 | DAPK2 | 0.38878935 |
| 134 | PRKCD | 0.38391440 |
| 135 | MAP3K11 | 0.37707145 |
| 136 | TAOK2 | 0.37136014 |
| 137 | ICK | 0.36847757 |
| 138 | CAMK4 | 0.36390650 |
| 139 | FGR | 0.34342572 |
| 140 | DYRK1B | 0.34245728 |
| 141 | RPS6KA4 | 0.33752257 |
| 142 | STK3 | 0.32120927 |
| 143 | NME2 | 0.30442741 |
| 144 | PRKACG | 0.29684321 |
| 145 | MTOR | 0.29646994 |
| 146 | ERBB2 | 0.29055317 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.31431053 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.15803028 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.06942520 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.02970541 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.02186802 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.81828858 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.64538463 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.44302628 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.38555739 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.34715822 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.33523336 |
| 12 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.28490107 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.04660500 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.04030536 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.03157400 |
| 16 | Notch signaling pathway_Homo sapiens_hsa04330 | 2.01794689 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.01680331 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.97913164 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.83880402 |
| 20 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.79275958 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.76556499 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.71010207 |
| 23 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.69748344 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.68010898 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.67038418 |
| 26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.63716656 |
| 27 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.63455172 |
| 28 | ABC transporters_Homo sapiens_hsa02010 | 1.60100047 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.58246020 |
| 30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.49948117 |
| 31 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.49482555 |
| 32 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.47749347 |
| 33 | Retinol metabolism_Homo sapiens_hsa00830 | 1.46468013 |
| 34 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.43760337 |
| 35 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.42502323 |
| 36 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.41982166 |
| 37 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.38908220 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.35150932 |
| 39 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.29603431 |
| 40 | Bile secretion_Homo sapiens_hsa04976 | 1.22663550 |
| 41 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.22633885 |
| 42 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.20102989 |
| 43 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.15004721 |
| 44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.14872187 |
| 45 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.09292633 |
| 46 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.09081406 |
| 47 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.09060603 |
| 48 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.08095933 |
| 49 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.07595267 |
| 50 | Lysine degradation_Homo sapiens_hsa00310 | 1.06960660 |
| 51 | Long-term potentiation_Homo sapiens_hsa04720 | 1.05744765 |
| 52 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.05556933 |
| 53 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.03346612 |
| 54 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.00772976 |
| 55 | Insulin secretion_Homo sapiens_hsa04911 | 1.00647549 |
| 56 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.00058814 |
| 57 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.99961580 |
| 58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.99659626 |
| 59 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.99509055 |
| 60 | Renin secretion_Homo sapiens_hsa04924 | 0.98443799 |
| 61 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.98374618 |
| 62 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.96637497 |
| 63 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.96577947 |
| 64 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.94924474 |
| 65 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.94559614 |
| 66 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.93781431 |
| 67 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.93521733 |
| 68 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.93513685 |
| 69 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.92768135 |
| 70 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.91938009 |
| 71 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.91741680 |
| 72 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.90854244 |
| 73 | Sulfur relay system_Homo sapiens_hsa04122 | 0.90258415 |
| 74 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.89255732 |
| 75 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.87955392 |
| 76 | * Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.86791569 |
| 77 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.86416492 |
| 78 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.86299557 |
| 79 | Other glycan degradation_Homo sapiens_hsa00511 | 0.86178447 |
| 80 | Carbon metabolism_Homo sapiens_hsa01200 | 0.85503073 |
| 81 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.85409448 |
| 82 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.85365310 |
| 83 | Platelet activation_Homo sapiens_hsa04611 | 0.82068044 |
| 84 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81745846 |
| 85 | Lysosome_Homo sapiens_hsa04142 | 0.79098853 |
| 86 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.78890599 |
| 87 | Leishmaniasis_Homo sapiens_hsa05140 | 0.78673141 |
| 88 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.77056544 |
| 89 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.76122389 |
| 90 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.75998413 |
| 91 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.75728268 |
| 92 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.75099827 |
| 93 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73944174 |
| 94 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.73604040 |
| 95 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.73473854 |
| 96 | Focal adhesion_Homo sapiens_hsa04510 | 0.73152333 |
| 97 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.71948696 |
| 98 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.71940308 |
| 99 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.70906378 |
| 100 | Circadian rhythm_Homo sapiens_hsa04710 | 0.70894624 |
| 101 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.70741402 |
| 102 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.70455788 |
| 103 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.68714340 |
| 104 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66929976 |
| 105 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.66412972 |
| 106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66255004 |
| 107 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.65293262 |
| 108 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.65204030 |
| 109 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.64243347 |
| 110 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.63837284 |
| 111 | Circadian entrainment_Homo sapiens_hsa04713 | 0.63577744 |
| 112 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.63070922 |
| 113 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.61992096 |
| 114 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.61789443 |
| 115 | Amoebiasis_Homo sapiens_hsa05146 | 0.60925282 |
| 116 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.60739603 |
| 117 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.60228027 |
| 118 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60016686 |
| 119 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.59919146 |
| 120 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.59804495 |
| 121 | Glioma_Homo sapiens_hsa05214 | 0.58761234 |
| 122 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.57689973 |
| 123 | Salivary secretion_Homo sapiens_hsa04970 | 0.57534497 |
| 124 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.56735388 |
| 125 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.56505731 |
| 126 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.54688215 |
| 127 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.52907193 |
| 128 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.52513185 |
| 129 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.52175356 |
| 130 | Pertussis_Homo sapiens_hsa05133 | 0.51906891 |
| 131 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.51089544 |
| 132 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50665263 |
| 133 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50358205 |
| 134 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.50140980 |
| 135 | Insulin resistance_Homo sapiens_hsa04931 | 0.49785535 |
| 136 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.49198655 |
| 137 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.48676700 |
| 138 | Endocytosis_Homo sapiens_hsa04144 | 0.47977574 |
| 139 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.47334708 |
| 140 | Melanogenesis_Homo sapiens_hsa04916 | 0.47070488 |
| 141 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.45470681 |
| 142 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.45147803 |
| 143 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.45052039 |
| 144 | Legionellosis_Homo sapiens_hsa05134 | 0.44973896 |
| 145 | Measles_Homo sapiens_hsa05162 | 0.44204445 |
| 146 | Malaria_Homo sapiens_hsa05144 | 0.43204363 |
| 147 | Prion diseases_Homo sapiens_hsa05020 | 0.43017738 |
| 148 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.42886521 |
| 149 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.41529876 |
| 150 | Tuberculosis_Homo sapiens_hsa05152 | 0.39796949 |
| 151 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.38791977 |
| 152 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.34452182 |
| 153 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31558234 |
| 154 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30491054 |
| 155 | Influenza A_Homo sapiens_hsa05164 | 0.29116713 |
| 156 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.28933849 |
| 157 | Metabolic pathways_Homo sapiens_hsa01100 | 0.27610629 |
| 158 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.23050714 |
| 159 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.22222915 |
| 160 | Hepatitis C_Homo sapiens_hsa05160 | 0.21381113 |
| 161 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.19818801 |
| 162 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.17967061 |
| 163 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.17929945 |
| 164 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.17051737 |

